Dynamic Technology Lab Private LTD Mirati Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $200,239 - $297,344	5,480 New	5,480 $204,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $92,463 - $134,731	1,554 Added 47.42%	4,831 $337,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $92,463 - $134,731	1,554 Added 47.42%	4,831 $337,000
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $202,574 - $458,896	-5,173 Reduced 61.22%	3,277 $220,000
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $640,679 - $1.28 Million	8,450 New	8,450 $695,000
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $591,552 - $738,330	-4,108 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $436,076 - $608,097	2,744 Added 201.17%	4,108 $704,000
Q4 2020 Feb 11, 2021	BUY	$162.05 - $240.27 $221,036 - $327,728	1,364 New	1,364 $300,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.